Free shipping on all orders over $ 500

Brimonidine Tartrate

Cat. No. M2468
Brimonidine Tartrate Structure
Synonym:

Brimonidine tartrate; AGN190342 tartrate; UK14304 tartrate

Size Price Availability Quantity
100mg USD 45  USD45 In stock
500mg USD 140  USD140 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Brimonidine Tartrate is a highly selective α-adrenergic receptor antagonist with an EC50 of 0.45 nM for α2A adrenoreceptor, and has been used to study open-angle glaucoma or ocular hypertension.

Chemical Information
Molecular Weight 442.22
Formula C15H16BrN5O6
CAS Number 70359-46-5
Solubility (25°C) DMSO 70 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Mitra Nejad, et al. Effect of over-the-counter brimonidine tartrate 0.025% ophthalmic solution on pupil size in healthy adults

[2] Xun Chen, et al. Effect of brimonidine tartrate 0.2% ophthalmic solution on visual quality after implantable collamer lens implantation with a central hole

[3] Ibrahim Tuncer, et al. Effect of brimonidine tartrate 0.15% on scotopic pupil size and upper eyelid position: controlled trial

[4] Daniel J Oh, et al. Brimonidine tartrate for the treatment of glaucoma

[5] Lana X Tong, et al. Brimonidine tartrate for the treatment of facial flushing and erythema in rosacea

Related Adrenergic Receptor Products
CRN04894

CRN04894 is an orally nonpeptide, potent and selective antagonist for adrenocorticotropic hormone (ACTH) acting at the melanocortin 2 receptor (MC2R). CRN04894 blocks the action of ACTH at MC2R, providing a potential novel treatment for the diseases of ACTH excess such as Cushing’s disease, congenital adrenal hyperplasia, and ectopic ACTH-secreting tumors.

(Des-His6)-ACTH (1-24) (human, bovine, rat)

(Des-His6)-ACTH (1-24) (human, bovine, rat) is an analogue of Adrenocorticotropic hormone (ACTH).

ACTH (1-14)

ACTH (1-14) is a fragment of adrenocorticotrophin, which regulates cortisol and androgen production.

Mibenratide

Mibenratide, a small cyclic peptide, is an adrenergic β1 receptor antagonist.

Conopeptide rho-TIA

Conopeptide rho-TIA is a peptide derived from the venom contained in the predatory sea snail Conus tulipa, has highly selective and noncompetitive inhibitor at human α1B-Adrenergic Receptor.

  Catalog
Abmole Inhibitor Catalog




Keywords: Brimonidine Tartrate, Brimonidine tartrate; AGN190342 tartrate; UK14304 tartrate supplier, Adrenergic Receptor, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.